François Niyonsaba

Dr. François Niyonsaba

Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
FNFrançois Niyonsaba
François Niyonsaba
HUHiroko Ushio
Hiroko Ushio
NNNobuhiro Nakano
Nobuhiro Nakano
WNWilliam Ng
William Ng
KSKoji Sayama
Koji Sayama
HOHideoki Ogawa
Hideoki Ogawa

1 August 2005 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
FNFrançois Niyonsaba
François Niyonsaba
HUHiroko Ushio
Hiroko Ushio
INIsao Nagaoka
Isao Nagaoka
KOKo Okumura
Ko Okumura
HOHideoki Ogawa
Hideoki Ogawa
In addition to its physical barrier against invading microorganisms, the skin produces antimicrobial peptides, human β-defensins (hBDs) and cathelicidin LL-37, that participate in the innate host defense. Because IL-18 is produced by keratinocytes and involved in skin diseases in which hBDs and LL-37 are highly expressed, we hypothesized that these peptides would activate keratinocytes to secrete IL-18. We found that hBD-2, -3, and -4 and LL-37, but not hBD-1, activated normal human keratinocytes to secrete IL-18; this secretion reached peak strength at 3 h. In addition, the combination of peptides resulted in a synergistic effect on IL-18 secretion. We also revealed that hBD-2, -3, and -4 and LL-37 increased IL-18 mRNA expression, and that IL-18 secretion was more enhanced in keratinocytes differentiated in vitro with high Ca2+-containing medium. Furthermore, because IL-18 secretion induced by hBDs and LL-37 could not be suppressed by caspase-1 or caspase family inhibitors, and because these peptides failed to increase caspase-1 activity, we suggest that hBD- and LL-37-induced IL-18 secretion is probably via a caspase-1-independent pathway. To determine the molecular mechanism involved, we demonstrated that IL-18 secretion was through p38 and ERK1/2 MAPK pathways, because the inhibitors of p38 and ERK1/2, but not JNK, almost completely nullified IL-18 secretion. Moreover, hBD-2, -3, and -4 and LL-37 could induce the phosphorylation of p38 and ERK1/2, but not JNK. Thus, the ability of hBDs and LL-37 to induce IL-18 secretion by keratinocytes provides a new mechanism for these peptides in innate immunity and an understanding of their role in the pathogenesis of skin disorders.

4 October 2007 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
YZY. Zheng
Y. Zheng
FNFrançois Niyonsaba
François Niyonsaba
HUH. Ushio
H. Ushio
INI. Nagaoka
I. Nagaoka
SIS. Ikeda
S. Ikeda
HOH. Ogawa
H. Ogawa

1 February 2007 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
XCXuejun Chen
Xuejun Chen
FNFrançois Niyonsaba
François Niyonsaba
HUHiroko Ushio
Hiroko Ushio
MHMutsuko Hara
Mutsuko Hara
HYHidenori Yokoi
Hidenori Yokoi
HOHideoki Ogawa
Hideoki Ogawa
Antimicrobial peptides human β‐defensins (hBD) are mainly produced by epithelia of several organs including skin, and participate in innate immunity by killing invading pathogens. Besides their microbicidal activities, hBD activate several inflammatory and immune cells. Since hBD are generated by tissues where mast cells are present, we hypothesized that these peptides could activate mast cells. In this study, we demonstrated that both hBD‐3 and hBD‐4 induced mast cell degranulation, prostaglandin D2 production, intracellular Ca2+ mobilization and chemotaxis. Furthermore, hBD‐3‐ and hBD‐4‐induced activation of mast cells was suppressed by pertussis toxin and U‐73122, inhibitors for G protein and phospholipase C, respectively. We further revealed that hBD‐3 and hBD‐4 increased vascular permeability in the skin, which was dependent on the presence of mast cells, because hBD‐3 and hBD‐4 failed to enhance vascular permeability in mast cell‐deficient Ws/Ws rats. We also demonstrated that hBD‐3 and hBD‐4 induced phosphorylation of MAPK p38 and ERK1/2, which were further required for hBD‐mediated mast cell activation, as evidenced by the inhibitory effects of p38 and ERK1/2 inhibitors on mast cell degranulation. Together, these findings suggest the key role of hBD in inflammatory responses by recruiting and activating mast cells, and increasing vascular permeability.

1 December 2005 in Journal of Dermatological Science
Verified
Journal Article
Closed access
FNFrançois Niyonsaba
François Niyonsaba
HOHideoki Ogawa
Hideoki Ogawa

1 January 2006 in Critical Reviews in Immunology
Verified
Journal Article
Closed access
FNFrançois Niyonsaba
François Niyonsaba
INIsao Nagaoka
Isao Nagaoka
HOHideoki Ogawa
Hideoki Ogawa
A cutaneous barrier defends the body against invading pathogenic microorganisms due to both innate and adaptive immunity. The innate immune system comprises hundreds of peptides/proteins, which have potent microbicidal activities at low concentrations. Among these microbicidal agents, an increasing body of research has suggested that a vast arsenal of antimicrobial peptides composed of defensins and cathelicidins are key players in cutaneous immunity. Mainly produced by phagocytes and epithelial cells, defensins and cathelicidins directly or indirectly kill a wide range of bacteria, fungi, and viruses. However, it is increasingly evident that these peptides not only act as endogenous antibiotics but also display additional roles, such as regulation of inflammatory and immune responses, chemoattracting immune or inflammatory cells to wound or infection/inflammation sites, acceleration of angiogenesis, promotion of wound healing, and reepithelization, and binding and neutralizing of lipopolysaccharides. Here, we review the skin-derived antimicrobial peptides with an emphasis on their role in skin immune responses. We present an overview of defensin and cathelicidin structure and expression, clarify their various functions beyond microbicidal properties, and describe their modes of action. Moreover, we discuss the roles of these peptides in skin diseases and highlight their possible use in near therapeutic development.